Tradestie Institutional Equity Comparison Engine

MTNB vs PFE โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PFE Overall Edge

PFE Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Pfizer Inc. (PFE) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MTNB trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus PFE at 9.3x Forward P/E and 29.1% operating margin (-0.4% YoY). In options structure, MTNB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PFE sits in CONSOLIDATION (28th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner PFE
MTNB N/M vs PFE 9.3x Fwd P/E
Growth & Margin Winner PFE
Op Margin 0.0% vs 29.1% ยท YoY -100.0% vs -0.4%
Momentum & Technical Winner PFE
1Y -31.4% vs +8.2% ยท 52W Pos 22% vs 50%
Options & Structure Winner PFE
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (28th %ile IV)
MTNB NYSE American
Matinas BioPharma Holdings, Inc.
Pharmaceutical Preparations
$0.81
-10.98% 1D
Market Cap $979,904
1M Return -46.7%
1Y Return -31.35%
Forward P/E N/M
Unified AI Score
54.6 / 100 HOLD
Tech 53.0 Fund 58.0 Flow 50.0 Mom 60.0
PFE NYSE
Pfizer Inc.
Pharmaceutical Preparations
$27.54
-1.85% 1D
Market Cap $159.9B
1M Return -7.74%
1Y Return +8.21%
Forward P/E 9.3x
Unified AI Score
50.2 / 100 HOLD
Tech 32.0 Fund 52.0 Flow 69.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MTNB -31.35% PFE +8.21% Spread: +39.56 pp (PFE Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period MTNB Revenue PFE Revenue MTNB Op. Margin PFE Op. Margin Margin Edge
FY2018 $0M $40.8B -12230.9% 27.3% PFE
FY2019 $0M $40.9B -21067.4% 39.2% PFE
FY2020 $0M $41.6B -15288.4% 22.0% PFE
FY2021 $0M $73.6B -74954.5% 29.8% PFE
FY2022 $0M $91.8B -771.3% 34.2% PFE
FY2023 $0M $50.9B -2168.4% 4.2% PFE
FY2024 N/A $63.6B N/A 12.6% PFE
FY2025 N/A $62.6B N/A 12.4% PFE

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MTNB (1) vs PFE (9)
Institutional Metric MTNB PFE Criterion Row Winner
Market Capitalization Scale $979,904 $159.9B Larger Scale PFE
Trailing P/E Ratio Valuation N/M 40.1x Lower Multiple PFE
Forward P/E Ratio Valuation N/M 9.3x Lower Multiple PFE
Revenue Growth (YoY) Growth -100.0% -0.4% Higher Growth PFE
Operating Margin (TTM) Profitability 0.0% 29.1% Higher Margin PFE
Net Profit Margin Profitability 0.0% 6.3% Higher Margin PFE
Return on Equity (ROE) Capital Efficiency -147.5% 4.5% Higher ROE PFE
52-Week Range Position Momentum 22% ($0โ€“$3) 50% ($24โ€“$31) Stronger Trend PFE
Beta / 30D Volatility Risk Regime -7.20ฮฒ ยท 147% Vol 0.19ฮฒ ยท 24% Vol Lower Realized Risk PFE
Unified Institutional Score Composite Signal 54.6 / 100 (HOLD) 50.2 / 100 (HOLD) Higher Composite MTNB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MTNB vs PFE Buy Guide
MTNB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MTNB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PFE CONSOLIDATION
55d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 28th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live PFE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MTNB nor PFE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.